The stock's rise snapped a four-day losing streak.
In the assessment of 12-month price targets, analysts unveil insights for Collegium Pharmaceutical, presenting an average target of $45.5, a high estimate of $50.00, and a low estimate of $36.00.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback